SENSUS HEALTHCARE INC (SRTS) Stock Price, Quote, News and Overview
NASDAQ:SRTS - Nasdaq - US81728J1097 - Common Stock - Currency: USD
SRTS Quote, Performance and Key Statistics
5.38
-0.18 (-3.24%)
The current stock price of SRTS is 5.38 USD. In the past month the price decreased by -23.25%. In the past year, price increased by 10.7%.
SRTS Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 28.89 | 234.01B | ||
| ISRG | INTUITIVE SURGICAL INC | 80.74 | 211.07B | ||
| BSX | BOSTON SCIENTIFIC CORP | 41.63 | 154.00B | ||
| SYK | STRYKER CORP | 31.4 | 145.92B | ||
| MDT | MEDTRONIC PLC | 16.84 | 115.33B | ||
| BDX | BECTON DICKINSON AND CO | 16.35 | 65.30B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27.98 | 43.23B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 20.29 | 41.62B | ||
| IDXX | IDEXX LABORATORIES INC | 40.25 | 37.07B | ||
| DXCM | DEXCOM INC | 53.81 | 34.68B | ||
| RMD | RESMED INC | 26.21 | 34.03B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 17.5 | 24.02B |
Related stock screener links
About SRTS
Company Profile
Sensus Healthcare, Inc. is a medical device company, which engages in the provision of treatment for both oncological and non-oncological skin conditions. The company is headquartered in Boca Raton, Florida and currently employs 35 full-time employees. The company went IPO on 2016-06-03. The firm is focused on providing non-invasive treatments for both oncological and non-oncological skin conditions. The firm uses a low-energy X-ray technology known as superficial radiation therapy (SRT). The firm incorporated SRT into its portfolio of treatment devices: the SRT-100, SRT-100+ and SRT-100 Vision. SRT-100, is a photon x-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers and other skin conditions such as keloids. The SRT-100 Vision provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. Its SRT-100+ offer remote diagnostics solutions, including operation tracking.
Company Info
SENSUS HEALTHCARE INC
851 Broken Sound Pkwy NW Ste 215
Boca Raton FLORIDA 33487 US
CEO: Joseph C. Sardano
Employees: 35
Company Website: https://sensushealthcare.com/
Investor Relations: http://sensushealthcare.com/investors/
Phone: 15619225808
SENSUS HEALTHCARE INC / SRTS FAQ
What is the stock price of SENSUS HEALTHCARE INC today?
The current stock price of SRTS is 5.38 USD. The price decreased by -3.24% in the last trading session.
What is the ticker symbol for SENSUS HEALTHCARE INC stock?
The exchange symbol of SENSUS HEALTHCARE INC is SRTS and it is listed on the Nasdaq exchange.
On which exchange is SRTS stock listed?
SRTS stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for SENSUS HEALTHCARE INC stock?
11 analysts have analysed SRTS and the average price target is 13.26 USD. This implies a price increase of 146.47% is expected in the next year compared to the current price of 5.38. Check the SENSUS HEALTHCARE INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is SENSUS HEALTHCARE INC worth?
SENSUS HEALTHCARE INC (SRTS) has a market capitalization of 88.77M USD. This makes SRTS a Micro Cap stock.
How many employees does SENSUS HEALTHCARE INC have?
SENSUS HEALTHCARE INC (SRTS) currently has 35 employees.
What are the support and resistance levels for SENSUS HEALTHCARE INC (SRTS) stock?
SENSUS HEALTHCARE INC (SRTS) has a resistance level at 5.85. Check the full technical report for a detailed analysis of SRTS support and resistance levels.
Is SENSUS HEALTHCARE INC (SRTS) expected to grow?
The Revenue of SENSUS HEALTHCARE INC (SRTS) is expected to grow by 25.1% in the next year. Check the estimates tab for more information on the SRTS EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy SENSUS HEALTHCARE INC (SRTS) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of SRTS, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of SRTS, evaluating the profitability, health, valuation and growth aspects
- SENSUS HEALTHCARE INC (SRTS) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- SENSUS HEALTHCARE INC (SRTS) Sales and EPS estimates to see what analysts future expectations are.
- SENSUS HEALTHCARE INC (SRTS) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- SENSUS HEALTHCARE INC (SRTS) Insider and Institutional Ownership to learn about the owners and their transactions.
- SENSUS HEALTHCARE INC (SRTS) Stock Chart to make your own analysis
- SENSUS HEALTHCARE INC (SRTS) Latest news and press-releases to stay up to date.
Does SENSUS HEALTHCARE INC (SRTS) stock pay dividends?
SRTS does not pay a dividend.
When does SENSUS HEALTHCARE INC (SRTS) report earnings?
SENSUS HEALTHCARE INC (SRTS) will report earnings on 2025-05-07, after the market close.
What is the Price/Earnings (PE) ratio of SENSUS HEALTHCARE INC (SRTS)?
The PE ratio for SENSUS HEALTHCARE INC (SRTS) is 13.45. This is based on the reported non-GAAP earnings per share of 0.4 and the current share price of 5.38 USD. Check the full fundamental report for a full analysis of the valuation metrics for SRTS.
What is the Short Interest ratio of SENSUS HEALTHCARE INC (SRTS) stock?
The outstanding short interest for SENSUS HEALTHCARE INC (SRTS) is 11.42% of its float. Check the ownership tab for more information on the SRTS short interest.
SRTS Technical Analysis
SRTS Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to SRTS. SRTS has an excellent financial health rating, but there are some minor concerns on its profitability.
SRTS Financial Highlights
Over the last trailing twelve months SRTS reported a non-GAAP Earnings per Share(EPS) of 0.4. The EPS increased by 1233.33% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 22.54% | ||
| ROA | 15.56% | ||
| ROE | 17.2% | ||
| Debt/Equity | 0 |
SRTS Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 82% to SRTS. The Buy consensus is the average rating of analysts ratings from 11 analysts.
For the next year, analysts expect an EPS growth of 6.59% and a revenue growth 25.1% for SRTS